Management of chronic kidney disease

Medicine (United Kingdom)

Volumn 43, Issue 8, 2015, Pages 454-461

  Tomson, Charlie ^a   Taylor, Dominic ^b  

^a FREEMAN HOSPITAL   (United Kingdom)

^b NORTH BRISTOL NHS TRUST   (United Kingdom)

Author keywords

Antihypertensive therapy; chronic disease management; chronic kidney disease; glomerulonephritis; progression

Indexed keywords

ALBUMIN; AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIEMETIC AGENT; ANTIHISTAMINIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTIPARKINSON AGENT; BARDOXOLONE METHYL; BICARBONATE; CALCIUM CHANNEL BLOCKING AGENT; CITRATE SODIUM; CLONAZEPAM; CODEINE; CREATININE; CYSTATIN C; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EZETIMIBE; HEMOGLOBIN A1C; LOOP DIURETIC AGENT; METFORMIN; NIFEDIPINE; SIMVASTATIN; THIAZIDE DIURETIC AGENT; VERAPAMIL;

ACIDOSIS; ACUTE KIDNEY FAILURE; ALBUMINURIA; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL (TOPIC); CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE CLASSIFICATION; DIURETIC THERAPY; DYSLIPIDEMIA; END STAGE RENAL DISEASE; GLOMERULUS FILTRATION RATE; GLYCEMIC CONTROL; HEMODYNAMICS; HUMAN; HYPERTENSION; HYPOTENSION; HYPOVOLEMIA; KIDNEY CLEARANCE; KIDNEY FAILURE; KIDNEY FIBROSIS; KIDNEY FUNCTION; MACROALBUMINURIA; NOCTURIA; OBESITY; PRIORITY JOURNAL; PROTEINURIA; PRURITUS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENAL REPLACEMENT THERAPY; RENOGRAPHY; RESTLESS LEGS SYNDROME; RISK FACTOR; RISK REDUCTION; SMOKING CESSATION; SYMPTOM; WEIGHT REDUCTION;

EID: 84938748458     PISSN: 13573039     EISSN: 13654357     Source Type: Journal    
DOI: 10.1016/j.mpmed.2015.05.004     Document Type: Review

References (25)

1. T. Bodenheimer, E.H. Wagner, and K. Grumbach Improving primary care for patients with chronic illness JAMA 288 2002 1775 1779
2. T. Bodenheimer, E.H. Wagner, and K. Grumbach Improving primary care for patients with chronic illness: the chronic care model Part 2 JAMA 288 2002 1909 1914
3. P.E. Stevens, S. de Lusignan, C.K.T. Farmer, and C.R.V. Tomson Engaging primary care in CKD initiatives: the UK experience Nephrol Dial Transpl 27 suppl 3 2012 iii5-iii11
4. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease Kidney Int Suppl 3 2013 1 150
5. National Institute for Health and Care Excellence Guideline CG182 Chronic kidney disease: early identification and management of chronic kidney disease in adults in primary and secondary care September 2014 National Institute for Health and Care Excellence (UK) London http://www.nice.org.uk/
6. S. Klahr The modification of diet in renal disease study N Engl J Med 320 1989 Mar 30 864 866
7. J.T. Wright Jr., G. Bakris, T. Greene, and et al. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial JAMA 288 2002 2421 2431
8. M.S. MacGregor, and M.W. Taal Detection, monitoring and care of patients with chronic kidney disease 5th edn August 2010 The Renal Association 2009 2011 Final version (28.2.2011) http://www.renal.org/guidelines/modules/detection-monitoring-and-care-of-patients-with-ckd#sthash.Lgk9HvL9.dpbs
9. National Institute for Health and Care Excellence guideline 127 Hypertension: clinical management of primary hypertension in adults September 2014 National Institute for Health and Care Excellence (UK) London http://www.nice.org.uk/
10. J.A. Arguedas, M.I. Perez, and J.M. Wright Treatment blood pressure targets for hypertension Cochrane Database Syst Rev 2009 Jul 8 Issue 3. Art. No.:CD004349
11. W.C. Cushman, G.W. Evans, R.P. Byington, et al. The ACCORD Study Group Effects of intensive blood-pressure control in type 2 diabetes mellitus N Engl J Med 362 2010 1575 1585
12. J. Lv, V. Perkovic, C.V. Foote, M.E. Craig, J.C. Craig, and G.F. Strippoli Antihypertensive agents for preventing diabetic kidney disease Cochrane Database Syst Rev 12 2012 Dec 12 CD004136 10.1002/14651858 Issue 12. Art. No.:CD004349
13. T.H. Jafar, P.C. Stark, C.H. Schmid, and et al. Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta analysis Ann Intern Med 139 2003 244 252
14. National Institute for Health and Care Excellence CG108 chronic heart failure National clinical guideline for diagnosis and management in primary and secondary care August 2010 http://www.nice.org.uk/guidance/cg108/resources/cg108-chronic-heart-failure-full-guideline3
15. J. Cheng, W. Zhang, and X. Zhang Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on all-cause mortality, cardiovascular deaths, and cardiovascular events in patients with diabetes mellitus: a meta-analysis JAMA Intern Med 174 2014 773 785
16. R. Kunz, C. Friedrich, M. Wolbers, and J.F. Mann Meta-analysis: effect of monotherapy and combination therapy with inhibitors of the renin angiotensin system on proteinuria in renal disease Ann Intern Med 148 2008 30 48
17. L.F. Fried, N. Emanuele, J.H. Zhang, and et al. Combined angiotensin inhibition for the treatment of diabetic nephropathy N Engl J Med 369 2013 1892 1903
18. P. Ruggenenti, A. Perna, R. Benini, and G. Remuzzi Effects of dihydropyridine calcium channel blockers, angiotensin-converting enzyme inhibition, and blood pressure control on chronic, nondiabetic nephropathies. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN) J Am Soc Nephrol 9 1998 2096 2101
19. J.E. Neter, B.E. Stam, F.J. Kok, D.E. Grobbee, and J.M. Geleijnse Influence of weight reduction on blood pressure. A meta-analysis of randomised controlled trials Hypertension 42 2003 e-publication
20. R.R. Holman, S.K. Paul, M.A. Bethel, D.R. Matthews, and H.A. Neil 10-Year follow-up of intensive glucose control in type 2 diabetes N Engl J Med 359 2008 1577
21. S.G. Coca, F. Ismail-Beigi, N. Haq, H.M. Krumholz, and C.R. Parikh Role of intensive glucose control in development of renal end points in type 2 diabetes mellitus: systematic review and meta-analysis intensive glucose control in type 2 diabetes Arch Intern Med 172 2012 761 769
22. S. Zoungas, A. Patel, J. Chalmers, et al. ADVANCE Collaborative Group Severe hypoglycaemia and risks of vascular events and death N Engl J Med 363 2010 Oct 7 1410 1418
23. R. Haynes, D. Lewis, J. Emberson, and et al. Effects of lowering LDL cholesterol on progression of kidney disease J Am Soc Nephrol 25 2014 1825 1833
24. M.K. Abramowitz, M.L. Melamed, C. Bauer, A.C. Raff, and T.H. Hostetter Effects of oral sodium bicarbonate in patients with CKD Clin J Am Soc Nephrol 8 2013 714 720
25. N.A. Smart, G. Dieberg, M. Ladhani, and T. Titus Early referral to specialist nephrology services for preventing the progression to end-stage kidney disease Cochrane Database Syst Rev 6 2014 June 18 CD007333 10.1002/14651858 Issue 6. Art. No.:CD004945